-
CytomX Therapeutics Reports Second Quarter 2023 Financial Results and Provides Business Update
08 Aug 2023 20:15 GMT
… Biopharma, Jazz Pharmaceuticals, VaxGen and Nabi Biopharmaceuticals (acquired by Biotest Pharmaceuticals). Ms … those relating to the potential benefits, safety and efficacy or progress … , and CX-2051, the potential benefits or applications of CytomX’s …
-
CalciMedica Expands Executive Team with New Appointments
23 May 2023 11:30 GMT
… Pharma, Leadiant BioSciences, Inc. and Nabi Biopharmaceuticals. While at BridgeBio Pharma, she … the potential to provide therapeutic benefits in life-threatening inflammatory diseases … regarding the design and potential benefits of Auxora; CalciMedica’s …
-
A Review of Immunotherapeutic Approaches for Substance Use Disorders: Current Status and Future Prospects
29 Sep 2022 00:11 GMT
… due to its potential therapeutic benefits.28
Fentanyl: Fentanyl is a … . 2013;2013(5):CD009329.
41. Nabi Biopharmaceuticals. Pharmacoeconomic Assessment in Nabi-4514 … , Chen CK, Lin SK. Potential benefit of lamotrigine in managing ketamine …
-
Cristal Therapeutics Announces Appointment of Edwin Klumper as Chief Medical Officer
29 Apr 2016 08:15 GMT
… SMS-oncology, he served at Nabi Biopharmaceuticals as Vice-President Marketing … . Cristal Therapeutics has demonstrated the benefits of CriPec® for various molecules …
-
Biopharmaceutical Contract Manufacturing Market to 2025 - Market To Grow At An Annual Rate Of 8.3%, Driven By The Rapidly Expanding Biopharmaceutical Market And Technological Advancements
11 Nov 2015 02:57 GMT
… some of the well-known benefits and a promising outlook, the … Transplant
- Nabi Biopharamaceuticals
- Nabi Biopharmaceuticals
- Nascent Biologics, Inc.
- …
-
Salah Kivlighn, Ph.D., Named Senior VP of Strategic Marketing and Program Operations at USP
17 Dec 2015 18:27 GMT
… marketing teams and initiatives at NABI Biopharmaceuticals and Merck & Co., Inc … ensure the quality, safety, and benefit of medicines and foods. USP …
-
Dr. Christine V. Sapan Named President of Asana Medical, Inc.
09 Nov 2015 16:34 GMT
… innovative companies including Neurologix (EVP), NABI Biopharmaceuticals (VP) and Beckman-Coulter.
… -30% of patients do not benefit from these therapies and have …
About
© 1995-2025